Below are six genetic databases and their drug industry partners:
1. 23andMe — which has genetic data from about 5 million individuals — partners with Genentech and GlaxoSmithKline.
2. deCODE Genetics — which has data from about 1.6 million people — partners with Amgen.
3. UK Biobank — which has data from 500,000 people — partners with AbbVie, Alnylam, AstraZeneca, Biogen, Bristol-Myers Squibb, GlaxoSmithKline, Pfizer, Regeneron and Takeda.
4. Geisinger — which supplies data from 250,000 people — partners with Regeneron.
5. Mayo Clinic — which supplies data from 100,000 people — partners with Regeneron.
6. FinnGen — which has data from about 147,000 people — partners with AbbVie, AstraZeneca, Biogen, Celgene, Genentech, GlaxoSmithKline, Merck & Co., Pfizer and Sanofi.
More articles on pharmacy:
Oklahoma opioid trial wraps: 10 takeaways
Drugmaker tried to shred records before FDA inspection, agency claims
Publix Pharmacy to deliver prescriptions to patients before hospital discharge
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.